Novo Nordisk A-S

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$78.17-$147.59
Market Cap
$368.4B
Shares Short
8M

Financials

See more
Revenue (12 Mos)
$270.5B
Revenue Growth (YoY)
21.4%
Gross Profit (12 Mos)
$229B
Diluted EPS
$2.95

News

See more

Yahoo Finance • 17 hours ago

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial’s Design – Hagens Berman

Yahoo Finance • yesterday

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cardlytics, Novo Nordisk, Micron, and ModivCare and Encourages Investors to Contact the Firm

Yahoo Finance • 2 days ago

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Yahoo Finance • 2 days ago

Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

About

CEO
Mr. Lars Fruergaard Jorgensen
CFO
Mr. Karsten Munk Knudsen
Address
Novo Alle 1, Bagsvaerd, Denmark, 2880
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
71,880